HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Tomaso Bottio Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bottio, T. Search for Related Content PubMed Articles by Bottio, T. Related Collections Anesthesia Valve disease

J Thorac Cardiovasc Surg 2008;136:538-539
© 2008 The American Association for Thoracic Surgery

Letter to the Editor

The present and the future in aortic stenosis management: Are there factors that might preclude surgery?

Cardiovascular Institute, University of Padua Medical School, Padua, Italy

The first 20% of the full text of this article appears below.

To the Editor:

I read with great interest the article by Bertrand Marcheix and associates.¹ I congratulate them for this well-designed study, but I also wish to add some brief comments. The aim was to determine the impact of less-invasive techniques for treatment of high-risk patients with aortic valve disease by using a self-expandable aortic bioprosthesis (CoreValve Inc, Paris, France) suitable for percutaneous retrograde delivery. The mean logistic EuroSCORE was 32%. Of 10 patients undergoing successful implants, 2 died within 30 days and a third died later, for an overall 30% hospital mortality. Vascular complications were observed in 5 patients. Mean intensive care unit stay was 4.6 days and hospital stay was 15 days. . . . [Full Text of this Article]